Average Co-Inventor Count = 4.11
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Aclaris Therapeutics, Inc. (8 from 20 patents)
2. Innov17 LLC (6 from 6 patents)
3. Confluence Life Sciences, Inc. (4 from 12 patents)
4. Other (2 from 832,843 patents)
5. Adaris Therapeutics, Inc. (1 from 1 patent)
6. Pfizer Corporation (4,455 patents)
21 patents:
1. 12297203 - Pyrrolopyrimidine ITK inhibitors
2. 12281111 - Substituted pyrrolopyridine JAK inhibitors and methods of making and using the same
3. 11820775 - Pyrrolopyrimidine ITK inhibitors
4. 11739086 - Substituted pyrrolopyridine JAK inhibitors and methods of making and using the same
5. 11420966 - Substituted pyrrolopyridines as JAK inhibitors
6. 11021482 - Pyrrolopyrimidine ITK inhibitors
7. 10981906 - Substituted pyrrolopyridine JAK inhibitors and methods of making and using the same
8. 10800775 - Pyrazolyl pyrrolo[2,3-b]pyrmidine-5-carboxylate analogs and methods of making the same
9. 10316038 - Pyrrolopyrimidine ITK inhibitors for treating inflammation and cancer
10. 10150783 - Heterocyclic ITK inhibitors for treating inflammation and cancer
11. 9884847 - Indazole retinoic acid receptor-related orphan receptor modulators and uses thereof
12. 9771374 - Benzimidazole retinoic acid receptor-related orphan receptor modulators and uses thereof
13. 9708268 - ROR modulators and their uses
14. 9701663 - Sulfonamide retinoic acid receptor-related orphan receptor modulators and uses thereof
15. 9695200 - Heterocyclic ITK inhibitors for treating inflammation and cancer